| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Authors (2008). Published by Oxford University Press. All rights reserved
Possible Impact of the NHK Special Questioning Cancer Treatment in Japan on Clinicians' Prescriptions of Oxaliplatin
1 Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan
2 Department of Internal Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
3 Department of Hematology and Oncology, Graduate School of Medicine and Hospital, University of Tokyo, Tokyo, Japan
4 Division of Social Medicine, Department of Healthcare Systems Research, Hokkaido University Graduate School of Medicine, Hokkaido, Japan
5 Division of Regenerative Medicine, Jichi Medical School, Tochigi, Japan
6 Institute for Health Promotion and Disease Prevention Research (IPR), Keck School of Medicine, University of Southern California, CA, USA
For reprints and all correspondence: Masahiro Kami, Department of Hematology and Oncology, Graduate School of Medicine and Hospital, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. E-mail: kami-tky{at}umin.ac.jp
Received September 3, 2007; accepted October 12, 2007
Medical information through media may influence physicians' prescriptions of medication. The Japan Broadcasting Corporation (NHK) aired on April and May 2005, a special program called Questioning Cancer Treatment in Japan, covering oxaliplatin. We investigated potential impact of this program on prescriptions, utilizing a post-marketing clinical trial monitoring of all patients receiving oxaliplatin. The post-marketing clinical trial reached the target sample size of 1200 by the 4th week of May, 44 weeks sooner than anticipated. The newly registered numbers of facilities and patients exhibited a bimodal peak in April and June. The viewer rating of NHK special was 8.3%, whereas three national newspapers and one weekly magazine took up the minor articles of oxaliplatin. In July 2007, 405 clinicians sent a written opinion to NHK, stating NHK special invites misperceptions and confusions to public. NHK special might have had an impact on clinicians' prescriptions of oxaliplatin.
Key Words: oxaliplatin television program post-marketing clinical trial colon cancer
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Takita, H. Narimatsu, M. Tomoko, Y. Kishi, N. Murashige, T. Hamaki, Y. Kodama, K. Yuji, Y. Tanaka, and M. Kami Study of Newspaper Reports Regarding Clinical Trials in Japan J. Clin. Oncol., April 20, 2009; 27(12): 2099 - 2101. [Full Text] [PDF] |
||||
![]() |
Y. Kishi, S. Nagamatsu, M. Takita, Y. Kodama, A. Hori, N. Hatanaka, T. Hamaki, E. Kusumi, K. Kobayashi, T. Matsumura, et al. Trends in Cancer Coverage in Japanese Newspapers J. Clin. Oncol., December 20, 2008; 26(36): 6017 - 6020. [Full Text] [PDF] |
||||
